Document Detail

Pseudogout Associated Hip Pain in a Patient with HIV Infection.
Jump to Full Text
MedLine Citation:
PMID:  21209737     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
HIV infection is a global pandemic, currently affecting approximately 77,000 people in the UK and 33 million people around the world. The infection has widespread effects on the body and can involve the musculoskeletal system. It is therefore important that orthopaedic surgeons are aware of the condition and its sequelae. We present the case of a 46-year-old man with a 10-year history of HIV who presented with acute hip pain, difficulty weight-bearing, and constitutional symptoms. Following radiological, microbiological, and serological tests a diagnosis of pseudogout was established following microscopic analysis of the hip joint aspirate. The patient's symptoms resolved completely following the joint aspiration and NSAID therapy. Studies have shown a relationship between HIV infection and gout. The virus has also been linked to osteonecrosis, osteopenia, bone and joint tuberculosis, and septic arthritis from rare pathogens. However, it is difficult to fully ascertain whether these conditions are related to the HIV infection itself or the HAART (highly active antiretroviral therapy). There are no previously reported cases of HIV-infected patients with pseudogout. The case is discussed with reference to the literature.
Authors:
Benan M Dala-Ali; Matthew Welck; Mary Anne Lloyd; Henry D Atkinson
Related Documents :
21320757 - Does initiation of hiv antiretroviral therapy influence patterns of syringe lending amo...
21245517 - Evaluating and managing cardiovascular disease risk factors in hiv-infected patients.
21214037 - Addressing tuberculosis in the context of malnutrition and hiv coinfection.
21188937 - Criminalizing hiv transmission or exposure: the context of francophone west and central...
9068467 - Cryptosporidiosis in hiv-infected patients: diagnostic sensitivity of stool examination...
20121167 - Regional heterogeneity and diversity in cytokine and chemokine production by astroglia:...
Publication Detail:
Type:  Journal Article     Date:  2010-12-20
Journal Detail:
Title:  Case reports in medicine     Volume:  2010     ISSN:  1687-9635     ISO Abbreviation:  Case Rep Med     Publication Date:  2010  
Date Detail:
Created Date:  2011-01-06     Completed Date:  2011-07-14     Revised Date:  2013-04-15    
Medline Journal Info:
Nlm Unique ID:  101512910     Medline TA:  Case Rep Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  842814     Citation Subset:  -    
Affiliation:
North Middlesex University Hospital, Sterling Way, London N18 1QX, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Case Report Med
Journal ID (publisher-id): CRIM
ISSN: 1687-9627
ISSN: 1687-9635
Publisher: Hindawi Publishing Corporation
Article Information
Download PDF
Copyright © 2010 Benan M. Dala-Ali et al.
open-access:
Received Day: 26 Month: 8 Year: 2010
Accepted Day: 3 Month: 11 Year: 2010
Print publication date: Year: 2010
Electronic publication date: Day: 20 Month: 12 Year: 2010
Volume: 2010E-location ID: 842814
ID: 3014845
PubMed Id: 21209737
DOI: 10.1155/2010/842814

Pseudogout Associated Hip Pain in a Patient with HIV Infection
Benan M. Dala-Ali1*
Matthew Welck1
Mary Anne Lloyd2
Henry D. Atkinson1
1North Middlesex University Hospital, Sterling Way, London N18 1QX, UK
2Watford General Hospital, Hertfordshire WD18 0HB, UK
Correspondence: *Benan M. Dala-Ali: benan@doctors.org.uk
[other] Academic Editor: Ingo W. Husstedt

1. Background

HIV infection is a global pandemic which in 2007 affected 77,000 people in the UK and 33 million people around the world, according to the World Health Organisation [1]. The infection has widespread systemic effects which include the musculoskeletal system. It is thus essential that orthopaedic surgeons are aware of the condition and its sequelae.

Antiretroviral therapies, first licensed in 1995, have altered the course of HIV and its manifestations. However, these drugs are also known to have a multitude of side effects including osteonecrosis and metabolic abnormalities.

We report the case of an HIV patient presenting with spontaneous non-traumatic hip pain, who following radiological, microbiological, and serological tests was diagnosed as suffering from pseudogout. This is the first reported case of an HIV-infected patient with hip pseudogout. The case is discussed in the context of HIV and other causes of acute joint pain.


2. Case Report

A 55-year-old HIV-positive Caucasian man presented with a one-day history of spontaneous-onset left hip pain. The patient described a similar episode in the contralateral hip in 1997, which had resolved with analgesia and rest.

He had been diagnosed with HIV in 2002 and was immediately commenced on “highly active antiretroviral therapy” (HAART) to control disease progression. His HIV treatment consisted of two nucleoside reverse transcriptase inhibitors (emtricitabine and tenofovir) given as a fixed-dose combination (Truvada 200/245) once per day and the protease inhibitor duranavir 800 mg boosted with ritonavir 100 mg once per day. The patient also had a history of hypercholesterolaemia and syphilis. He was a non-smoker and an infrequent drinker.

On presentation he was mildly pyrexial and was unable to weight-bear through pain. There was a reduced range of both active and passive left hip movement (20–75 degrees flexion and 10-0-10 degrees of rotation), and it was held in 30 degrees of flexion at rest. Other musculoskeletal and neurological examinations were essentially normal. Blood investigations initially found a normal white blood cell count (WCC) of 8.3 × 109/L, C-reactive protein (CRP) of <3 U/L, erythrocyte sedimentation rate (ESR) of 10 mm/hr, Creatine Kinase (CK) of 88 U/L (normal 25–150 U/L), and negative ANA and ANCA.

Plain radiographs of the pelvis demonstrated only mild bilateral osteoarthritis (see Figure 1).

The patient was admitted under the HIV physicians for bed rest, analgesia, and observation; however he did not improve. Over the subsequent two days his CRP increased to 109, ESR to 90, though his white cells remained stable (WCC of 8.1 × 109/L). An MRI scan revealed a large left hip effusion and a moderate right hip effusion (see Figure 2).

An aspiration of the left hip was performed under local anaesthetic and revealed a turbid yellow fluid, which was sent for microbiology and cytology. A differential count of the aspirate showed 95% neutrophils, and gram staining found no bacteria present. Microscopy revealed positively birefringent crystals, consistent with calcium pyrophosphate. A diagnosis of hip pseudogout was made and the patient was commenced on high-dose nonsteroidal anti-inflammatory drugs (NSAIDs). The patient improved clinically over the next 48 hours and was discharged home fully weight-bearing. He was followed up in both the orthopaedic and rheumatology clinics, where the latter excluded any other major risk factors for the development of pseudogout. He remained well at 6-month review.


3. Discussion

HIV has been linked with a variety of orthopaedic and rheumatological conditions. The first documented association in 1987 was between AIDS and Reiter's Syndrome, followed by gout, osteoporosis, avascular necrosis, septic arthritis, osteomyelitis, and tuberculosis [2].

30%–40% of HIV/AIDS patients suffer from arthralgia. Though this can affect any joint, the knees, shoulders, and elbows are most commonly affected. When presented with such a patient, the orthopaedic surgeon must be aware of the possible differential diagnoses.

3.1. Gout

Gout is estimated to affect around 0.5% of HIV/AIDS patients per year [3, 4]. These patients often have urate abnormalities, 41% with hyperuricaemia and 5% with hypouricaemia, unlike HIV-negative patients whose urate levels are usually normal [5]. The elevated urate is likely to be the result of the HAART treatment itself [68] rather than of the HIV infection, and drugs such as the protease inhibitor ritonavir are known to have this association [9]. There are several hypotheses for why HAART might cause hyperuricaemia. The drugs may cause mitochondrial toxicity, which can increase the formation of lactate, which then competes with urate for tubular secretion in the kidneys. HAART drugs may also cause a respiratory chain failure that results in ATP depletion, which then increases urate production in the purine nucleotide cycle [10, 11]. Thirdly, HAART drugs cause hyperlipidaemia, insulin resistance, and central adiposity, which in turn can lead to gout.

3.2. Pseudogout

Despite the association between gout and HIV, there have been no documented cases of pseudogout-associated arthralgia. Whilst most cases of pseudogout are idiopathic, there are relationships with trauma, aging, and metabolic diseases, including hyperparathyroidism and haemochromatosis. Calcium pyrophosphate crystals in pseudogout are thought to develop from an increased adenosine triphosphate breakdown, which can lead to increased pyrophosphate levels in the joint [12].

It is difficult to know whether the HIV infection or HAART therapy was directly responsible for the pseudogout or whether it was secondary to another condition. Studies have shown a link between HIV or HAART and hypophosphatemia [13], hyperparathyroidism [14], hypothyroidism [15], and hypercalcaemia [16]. All these conditions are known risk factors of pseudogout.

3.3. Septic Arthritis

Septic arthritis usually presents with a short history of joint pain and fever, with a raised ESR and an absence of peripheral leukocytosis. It is more prevalent in HIV/AIDS patients that are intravenous drug users or haemophiliacs [17, 18], and the majority resolve with appropriate intravenous antibiotics [5]. However, if the patient fails to improve on the antibiotics, an open drainage of the joint should be performed in theatre. The most common pathogens are Staphylococcus aureus (60%) and Candida albicans (20%), and rarely pathogens such as Stenotrophomonas maltophilia and Proteus wickerhamii [19].

3.4. Tuberculosis

There has been a dual global epidemic of tuberculosis (TB) and HIV/AIDS. The World Health Organisation estimated that there were 9.27 million new cases of TB in 2007 (139 per 100,000 population); of these 1.37 million (14.8%) were HIV positive. The two conditions are interlinked, as the HIV-virus specifically eliminates macrophages and CD4 lymphocytes, which are cells essential for the prevention of active tuberculosis.

There has been an increased incidence of extrapulmonary TB, including bone and joint TB, in HIV/AIDS patients [20]. The diagnosis of skeletal TB is often delayed in developed countries, as it is not commonly encountered.

The most common site of musculoskeletal TB among HIV/AIDS patients is the spine (Pott's spine) [5]. The infection can also affect the weight-bearing joints, in particular the knee and hip. It presents with chronic pain with minimal inflammation. TB osteomyelitis classically presents with pain and swelling of the bone and surrounding soft tissues. There may also be enlarged regional lymphadenopathy or the presence of an abscess or sinus.

3.5. Osteopenia/Osteoporosis

HAART causes metabolic changes in the body and has been shown to cause osteopenia and osteoporosis, putting patients at risk of low-energy fractures. A study of 600 HIV-infected individuals on antiretroviral therapy demonstrated a significantly higher prevalence of osteopenia compared to the national average in the US [21].

The underlying mechanism of bone loss in HIV-infected patients is not fully understood. Studies using markers of bone formation and resorption have shown an uncoupling of these events in individuals with HIV infection [22]. Other studies have found an increased number of proinflammatory cytokines tumour necrosis factor (TNF) and interleukin-6 (IL-6) in the HIV-infected patients, which have an important role in osteoclast activation and resorption [23].

3.6. Osteonecrosis

HIV/AIDs patients have an increased risk of developing osteonecrosis, believed to occur as a result of a vascular thrombosis, caused either by the actions of anticardiolipin antibodies or by a deficiency of protein S [24]. A study using magnetic resonance imaging (MRI) of 339 HIV-positive patients found that 4.4% suffered from asymptomatic osteonecrosis [25]. It is unclear whether this is the result of the HIV virus, the HAART treatment, or an increased appreciation of osteonecrosis on scans. The protease inhibitor drugs have been specifically reported to lead to osteonecrosis [26, 27].


4. Conclusion

HIV/AIDS is a global phenomenon and it is essential that clinicians are aware of its widespread effects and those of its drug treatments. This is the first documented case of hip pseudogout in an HIV/AIDS patient. Though it is unclear whether this was the result of the HIV infection, the HAART treatment, or an unrelated cause, the cases highlight the diagnostic difficulties one can encounter in these susceptible patients.


Conflict of Interests

There is no conflict of interests. The authors received no financial or other type of support to carry out this study. This is an original paper and has not been published in any other journal. All authors read and approved this paper for publishing purposes.


Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.


Authors' Contributions

B. M. Dala-Ali, M. Welck, and H. D. Atkinson managed the patient. B. M. Dala-Ali and M. A. Lloyd wrote the paper. M. Welck and H. D. Atkinson assisted with the literature review and paper preparation. All authors have read and approved the final paper.


References
1. UNAIDS2008 report on the global AIDS epidemicYear: 2008Geneva, SwitzerlandUNAIDS
2. Buskila D,Gladman DD,Langevitz P,Bookman AAM,Fanning M,Salit IE. Rheumatologic manifestations of infection with the human immunodeficiency virus (HIV)Clinical and Experimental RheumatologyYear: 1990865675732289325
3. Berman A,Espinoza LR,Diaz JD,et al. Rheumatic manifestations of human immunodeficiency virus infectionAmerican Journal of MedicineYear: 198885159643260453
4. Hacbarth ET,Freire CA,Atra E. Rheumatic manifestations of acquired immunodeficiency syndrome (AIDS)Manifestações reumáticas na síndrome de imunodeficiência adquirida (AIDS)Revista da Associacao Medica BrasileiraYear: 199238290941307073
5. Medina-Rodriguez F,Guzman C,Jara LJ,et al. Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factorsJournal of RheumatologyYear: 19932011188018848308773
6. Lambert JS,Seidlin M,Reichman RC,et al. 2’,3’-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A Phase I trialNew England Journal of MedicineYear: 199032219133313402139173
7. Richardson D,Liou SH,Kahn JO. Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS clinical trials group protocols 116A and 116B/117Journal of Acquired Immune Deficiency SyndromesYear: 1993611121212238229656
8. Walker UA,Hoffmann C,Enters M,Thoden J,Behrens G,Mitzel SL. High serum urate in HIV-infected persons: the choice of the antiretroviral drug mattersAIDSYear: 200620111556155816847413
9. Creighton S,Miller R,Edwards S,Copas A,French P. Is ritonavir boosting associated with gout?International Journal of STD and AIDSYear: 200516536236415949066
10. Becker MA,Roessler BJ. Scriver CR,Beaudet AL,Sly WS,Valle DHyperuricaemia and goutThe Metabolic and Molecular Basis of Inherited DiseaseYear: 19957th editionchapter 49New York, NY, USAMcGraw Hill
11. Mineo I,Tarui S. Myogenic hyperuricemia: what can we learn from metabolic myopathies?Muscle and NerveYear: 1995183S75S817603532
12. Rothschild BM. Calcium Pyrophosphate Deposition Disease (rheumatology) 2008, http://www.emedicine.com/radio/topic125.htm.
13. Day SL,Leake Date HA,Bannister A,Hankins M,Fisher M. Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practiceJournal of Acquired Immune Deficiency SyndromesYear: 200538330130415735448
14. Rosenvinge MM,Gedela K,Copas AJ,et al. Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiencyJournal of Acquired Immune Deficiency SyndromesYear: 201054549649920672448
15. Nelson M,Powles T,Zeitlin A,et al. Thyroid dysfunction and relationship to antiretroviral therapy in hiv-positive individuals in the HAART eraJournal of Acquired Immune Deficiency SyndromesYear: 200950111311419092451
16. Thomas J,Doherty SM. HIV infection—a risk factor for osteoporosisJournal of Acquired Immune Deficiency SyndromesYear: 200333328129112843738
17. Ventura G,Gasparini G,Lucia MB,et al. Osteoarticular bacterial infections are rare in HIV-infected patients: 14 cases found among 4023 HIV-infected patientsActa Orthopaedica ScandinavicaYear: 19976865545589462355
18. Barzilai A,Varon D,Martinowitz U,Heim M,Schulman S. Characteristics of septic arthritis in human immunodeficiency virus-infected haemophiliacs versus other risk groupsRheumatologyYear: 199938213914210342626
19. Pascual JS,Balos LL,Baer AN. Disseminated Prototheca wickerhamii infection with arthritis and tenosynovitisJournal of RheumatologyYear: 20043191861186515338515
20. Jellis JE. Bacterial infections: bone and joint tuberculosisBailliere’s Clinical RheumatologyYear: 1995911511597728878
21. Gallant JE,Staszewski S,Pozniak AL,et al. Efficacy and safety of tenofovir DF vs. stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trialJournal of the American Medical AssociationYear: 2004292219120115249568
22. Amorosa V,Tebas P. Bone disease and HIV infectionClinical Infectious DiseasesYear: 200642110811416323100
23. Thomas J,Doherty SM. HIV infection—a risk factor for osteoporosisJournal of Acquired Immune Deficiency SyndromesYear: 200333328129112843738
24. Rademaker J,Dobro JS,Solomon G. Osteonecrosis and human immunodeficiency virus infectionJournal of RheumatologyYear: 19972436016049058674
25. Miller KD,Masur H,Jones EC,et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adultsAnnals of Internal MedicineYear: 20021371172412093241
26. Meyer D,Behrens G,Schmidt RE,Stoll M. Osteonecrosis of the femoral head in patients receiving HIV protease inhibitorsAIDSYear: 19991391147114810397552
27. Blangy H,Loeuille D,Chary-Valckenaere I,Christian B,May T,Gillet P. Osteonecrosis of the femoral head in HIV-1 patients: four additional casesAIDSYear: 200014142214221511061670

Article Categories:
  • Case Report


Previous Document:  Hot water epilepsy in a pregnant woman: a case report.
Next Document:  HIV Wasting Syndrome in a Nigerian Failing Antiretroviral Therapy: A Case Report and Review of the L...